Business & Strategy Consulting

• Corporate strategy consulting
• Therapy area strategy consulting
• Product development plan consulting

Genomics / Translational Medicine

• Precision Medicine
• Translational medicine
• Genotype
• Outcomes / response predictors
• Computational biology​​​​​​

Study Optimization

• Population targeting
• Study design
• Endpoint selection
• Unmet need
• Time – cost – quality modeling
• Alternative models

Patient & Site Recruitment
and Feasibility

• Eligibility criteria modeling
• Feasibility assessment
• Enrollment and timeline assessment
• Probability of success assessment

Patient Safety / Pharmacovigilance

• Pre- and Post- market authorization Case processing of clinician reported adverse event data
• Regulatory reporting
• Safety signal detection
• Evolving to address better sampling of data, workforce efficiency, more robust analysis

Real-World Evidence Generation

• Standard of care based research
• Outcomes based studies
• Label expansion studies
• Hybrid data models
• Virtual studies
• EMR based cohort models
• Direct with Patient studies

Market Access Planning

• Health economic modeling
• Landscape assessment
• Pricing and market access consulting
• Product value
• HTA panels, submissions
• Product development strategy